Palbociclib in Combination With Fulvestrant Versus Fulvestrant in Advanced Breast Cancer: A Real-world Study in China

NCT04526028 · clinicaltrials.gov ↗

UNKNOWN

Status

612

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Fulvestrant
Palbociclib

Interventions

DRUG: Fulvestrant Injectable Product
DRUG: Palbociclib

Sponsor

Tianjin Medical University Cancer Institute and Hospital